NEW YORK (GenomeWeb News) — Compugen today reported zero revenues for the third quarter as net losses declined 30 percent.
Receipts for the three months ended Sept. 30, 2005, were $95,000, Compugen said.
R&D spending for the quarter declined 26 percent to $1.7 million from $2.3 million in 2005.
Compugen said net losses in the quarter declined 30 percent to $2.5 million  percent from $3.6 million year over year.  

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.